As the prevalence of obesity continues to rise worldwide, GLP-1 receptor agonists such as Ozempic and Wegovy have gained significant attention from both healthcare professionals and patients seeking clinically proven, non-surgical weight loss solutions
Pader I, Sengupta R, Cebula M, Xu J, Lundberg JO, Holmgren A, Johansson K, and Arner ES
GLP-1 agonists are generally safe and well-tolerated, but ongoing monitoring ensures any issues are identified and managed promptly, optimising both your diabetes control and cardiovascular health
It is hard to explain the heterogeneity given that two of the larger studies were conducted by the same research group using the same methodology [46, 47]
Additionally, Methionine may increase stimulation of the mammalian target of Rapamycin (mTOR)